Xantech Pharmaceuticals, Inc.
Records under this name other than patents Xantech Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Xantech Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,201,914 | Combination antiperspirant and antimicrobial composition Formerly held Term ended Term ended May 15, 2024 · USPTO record | Term ended | Term ended May 15, 2024 | USPTO record |
| US 7,427,389 | Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes Formerly held Lapsed on the fee record Ended Sep 23, 2020 · USPTO record | Lapsed on the fee record | Ended Sep 23, 2020 | USPTO record |
| US 6,451,597 | Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins Formerly held Term ended Term ended Apr 6, 2020 · Medium confidence | Term ended | Term ended Apr 6, 2020 | Medium confidence |
| US 6,468,777 | Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins Formerly held Term ended Term ended Apr 6, 2020 · Medium confidence | Term ended | Term ended Apr 6, 2020 | Medium confidence |
| US 6,495,360 | Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins Formerly held Term ended Term ended Apr 6, 2020 · USPTO record | Term ended | Term ended Apr 6, 2020 | USPTO record |
| US 6,541,223 | Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins Formerly held Term ended Term ended Apr 6, 2020 · Medium confidence | Term ended | Term ended Apr 6, 2020 | Medium confidence |
| US 7,338,652 | Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents Formerly held Lapsed on the fee record Ended Mar 4, 2020 · USPTO record | Lapsed on the fee record | Ended Mar 4, 2020 | USPTO record |
| US 6,986,740 | Ultrasound contrast using halogenated xanthenes Formerly held Term ended Term ended Aug 3, 2019 · USPTO record | Term ended | Term ended Aug 3, 2019 | USPTO record |
| US 6,991,776 | Intracorporeal medicaments for high energy phototherapeutic treatment of disease Formerly held Term ended Term ended Feb 24, 2019 · USPTO record | Term ended | Term ended Feb 24, 2019 | USPTO record |
| US 6,331,286 | Methods for high energy phototherapeutics Formerly held Term ended Term ended Dec 21, 2018 · USPTO record | Term ended | Term ended Dec 21, 2018 | USPTO record |